Analysts Remain Bullish on Vertex with Price Target Increases
On March 2, 2024, JMP Securities analyst Joe Goodwin reiterated a Market Outperform rating on Vertex (NASDAQ: VERX) and increased ...
Tag: VERX
Analysts Upgrade Vertex Pharmaceuticals with Bullish Price Targets
On March 1, 2024, analyst Adam Hotchkiss from Goldman Sachs upgraded Vertex (NASDAQ:VERX) to a Buy rating and raised the ...
Analysts Express Optimistic and Pessimistic Views on Vertex Pharmaceuticals A Comprehensive Overview
As of January 12, 2024, a total of six analysts have shared their assessments of Vertex (NASDAQ: VRTX) over the ...
Popular News
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
-
Strategic Shift: Kazatomprom Curtails Production and Denies Listing Rumors
-
NextGen Healthcare Charts Course for Behavioral Health Transformation
